Investigación / Grupos de investigación

Grupo  301

Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Publicaciones (892)

  • Moreno, C; Wykes, T; Galderisi, S; Nordentoft, M; Crossley, N; Jones, N; Cannon, M; Correll, CU; Byrne, L; Carr, S; Chen, EYH; Gorwood, P; Johnson, S; Karkkainen, H; Krystal, JH; Lee, J; Lieberman, J; Lopez-Jaramillo, C; Mannikko, M; Phillips, MR; Uchida, H; Vieta, E; Vita, A; Arango, C.

    How mental health care should change as a consequence of the COVID-19 pandemic

    Lancet Psychiatry. 2020; 7(9): 813-824 Nº de citas: 998 [doi:10.1016/S2215-0366(20)30307-2]

  • Siafis, S; Ciray, O; Schneider-Thoma, J; Bighelli, I; Krause, M; Rodolico, A; Ceraso, A; Deste, G; Huhn, M; Fraguas, D; Mavridis, D; Charman, T; Murphy, DG; Parellada, M; Arango, C; Leucht, S.

    Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis

    Molecular Autism. 2020; 11(1): Nº de citas: 53 [doi:10.1186/s13229-020-00372-z]

  • Deters, RK; Naaijen, J; Rosa, M; Aggensteiner, PM; Banaschewski, T; Saam, MC; Schulze, UME; Sethi, A; Craig, MC; Sagar-Ouriaghli, I; Santosh, P; Castro-Fornieles, J; Penzol, MJ; Arango, C; Werhahn, JE; Brandeis, D; Franke, B; Glennon, J; Buitelaar, JK; Hoekstra, PJ; Dietrich, A.

    Executive functioning and emotion recognition in youth with oppositional defiant disorder and/or conduct disorder

    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2020; 21(7): 539-551 Nº de citas: 27 [doi:10.1080/15622975.2020.1747114]

  • Boada, L; Lahera, G; Pina-Camacho, L; Merchan-Naranjo, J; Diaz-Caneja, CM; Bellon, JM; Ruiz-Vargas, JM; Parellada, M.

    Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. 2020; 50(8): 3046-3059 Nº de citas: 29 [doi:10.1007/s10803-020-04408-4]

  • van Os, J; Pries, LK; Delespaul, P; Kenis, G; Luykx, JJ; Lin, BCD; Richards, AL; Akdede, B; Binbay, T; Altinyazar, V; Yalincetin, B; Gumus-Akay, G; Cihan, B; Soygur, H; Ulas, H; Cankurtaran, ES; Kaymak, SU; Mihaljevic, MM; Petrovic, SA; Mirjanic, T; Bernardo, M; Cabrera, B; Bobes, J; Saiz, PA; Garcia-Portilla, MP; Sanjuan, J; Aguilar, EJ; Santos, JL; Jimenez-Lopez, E; Arrojo, M; Carracedo, A; Lopez, G; Gonzalez-Penas, J; Parellada, M; Maric, NP; Atbasoglu, C; Ucok, A; Alptekin, K; Saka, MC; Arango, C; O'Donovan, M; Rutten, BPF; Guloksuz, S; Genetic Risk Outcome Investigators.

    Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study

    PSYCHOLOGICAL MEDICINE. 2020; 50(11): 1884-1897 Nº de citas: 34 [doi:10.1017/S003329171900196X]

  • Lei, D; Pinaya, WHL; van Amelsvoort, T; Marcelis, M; Donohoe, G; Mothersill, DO; Corvin, A; Gill, M; Vieira, S; Huang, XQ; Lui, S; Scarpazza, C; Young, J; Arango, C; Bullmore, E; Qiyong, G; McGuire, P; Mechelli, A.

    Detecting schizophrenia at the level of the individual: relative diagnostic value of whole-brain images, connectome-wide functional connectivity and graph-based metrics

    PSYCHOLOGICAL MEDICINE. 2020; 50(11): 1852-1861 Nº de citas: 61 [doi:10.1017/S0033291719001934]

  • Gonzalez-Penas, J; Costas, JC; Garcia-Alcon, A; Penzol, MJ; Rodriguez, J; Rodriguez-Fontenla, C; Alonso-Gonzalez, A; Fernandez-Prieto, M; Carracedo, A; Arango, C; Parellada, M.

    Psychiatric comorbidities in Asperger syndrome are related with polygenic overlap and differ from other Autism subtypes

    Translational Psychiatry. 2020; 10(1): Nº de citas: 14 [doi:10.1038/s41398-020-00939-7]

  • Tandon, R; Lenderking, WR; Weiss, C; Shalhoub, H; Barbosa, CD; Chen, J; Greene, M; Meehan, SR; Duvold, LB; Arango, C; Agid, O; Castle, D.

    The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey

    Annals of General Psychiatry. 2020; 19(1): Nº de citas: 61 [doi:10.1186/s12991-020-00292-5]

  • Berge, D; Mane, A; Lesh, TA; Bioque, M; Barcones, F; Gonzalez-Pinto, AM; Parellada, M; Vieta, E; Castro-Fornieles, J; Rodriguez-Jimenez, R; Garcia-Portilla, MP; Usall, J; Carter, CS; Cabrera, B; Bernardo, M; Janssen, J; Mezquida, G; Amoretti, S; Pina-Camacho, L; Arango, C; Gonzalez-Ortega, I; Garcia, S; De-la-Camara, C; Fayed, N; Sanjuan, J; Aguilar, EJ; Guo, JY; Salgado, P; Radua, J; Sanchez-Moreno, J; de la Serna, E; Baeza, I; Contreras-Fernandez, F; Saiz-Masvidal, C; Gonzalez-Blanco, L; Jimenez-Trevino, L; Dompablo, M; Torio, I; Butjosa, A; Rubio-Abadel, E; Sarro, S; Pomarol-Clotet, E; PEPs Grp Collaborators.

    Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness

    SCHIZOPHRENIA BULLETIN. 2020; 46(4): 846-856 Nº de citas: 16 [doi:10.1093/schbul/sbz132]

  • Mas, S; Boloc, D; Rodriguez, N; Mezquida, G; Amoretti, S; Cuesta, MJ; Gonzalez-Penas, J; Garcia-Alcon, A; Lobo, A; Gonzalez-Pinto, A; Corripio, I; Vieta, E; Castro-Fornieles, J; Mane, A; Saiz-Ruiz, J; Gasso, P; Bioque, M; Bernardo, M; PEPs Grp.

    Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis Cohort

    SCHIZOPHRENIA BULLETIN. 2020; 46(4): 1019-1025 Nº de citas: 35 [doi:10.1093/schbul/sbaa012]

  • Pina-Camacho, L; Boada, L; Diaz-Caneja, CM; Garcia-Alcon, A; Burdeus, M; Serrano-Drozdowskyj, E; Fraguas, D; Moreno, C; Parellada, M.

    The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in young people with autism and schizophrenia

    REVISTA DE PSIQUIATRIA Y SALUD MENTAL. 2020; 13(3): 118-130 Nº de citas: 14 [doi:10.1016/j.rpsm.2020.05.006]

  • Camarillo, L; Ferre, F; Echeburua, E; Amor, PJ.

    Partner's Emotional Dependency Scale: Psychometrics

    ACTAS ESPANOLAS DE PSIQUIATRIA. 2020; 48(4): 145-153 Nº de citas: 14

  • Boloc, D; Rodriguez, N; Torres, T; Garcia-Cerro, S; Parellada, M; Saiz-Ruiz, J; Cuesta, MJ; Bernardo, M; Gasso, P; Lafuente, A; Mas, S; Arnaiz, JA.

    Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms

    PSYCHOPHARMACOLOGY. 2020; 237(7): 2151-2159 Nº de citas: 3 [doi:10.1007/s00213-020-05526-8]

  • Fusar-Poli, P; de Pablo, GS; Correll, CU; Meyer-Lindenberg, A; Millan, MJ; Borgwardt, S; Galderisi, S; Bechdolf, A; Pfennig, A; Kessing, LV; van Amelsvoort, T; Nieman, DH; Domschke, K; Krebs, MO; Koutsouleris, N; McGuire, P; Do, KQ; Arango, C.

    Prevention of Psychosis Advances in Detection, Prognosis, and Intervention

    JAMA Psychiatry. 2020; 77(7): 755-765 Nº de citas: 394 [doi:10.1001/jamapsychiatry.2019.4779]

  • Jongs, N; Jagesar, R; van Haren, NEM; Penninx, BWJH; Reus, L; Visser, PJ; van der Wee, NJA; Koning, IM; Arango, C; Sommer, IEC; Eijkemans, MJC; Vorstman, JA; Kas, MJ.

    A framework for assessing neuropsychiatric phenotypes by using smartphone-based location data

    Translational Psychiatry. 2020; 10(1): Nº de citas: 35 [doi:10.1038/s41398-020-00893-4]

  • Baandrup, L; Allerup, P; Nielsen, MO; Bak, N; During, SW; Leucht, S; Galderisi, S; Mucci, A; Bucci, P; Arango, C; Diaz-Caneja, CM; Dazzan, P; McGuire, P; Demjaha, A; Ebdrup, BH; Kahn, RS; Glenthoj, BY.

    Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial

    PSYCHIATRY RESEARCH. 2020; 289: Nº de citas: 12 [doi:10.1016/j.psychres.2020.112970]

  • Calvo, A; Roddy, DW; Coughlan, H; Kelleher, I; Healy, C; Harley, M; Clarke, M; Leemans, A; Frodl, T; O'Hanlon, E; Cannon, M.

    Reduced hippocampal volume in adolescents with psychotic experiences: A longitudinal population-based study

    PLoS One. 2020; 15(6): Nº de citas: 14 [doi:10.1371/journal.pone.0233670]

  • Mas, S; Gasso, P; Rodriguez, N; Cabrera, B; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Parellada, M; Corripio, I; Vieta, E; Castro-Fornieles, J; Bobes, J; Usall, J; Saiz-Ruiz, J; Contreras, F; Parellada, E; Bernardo, M; Lafuente, A; Bioque, M; Diaz-Caneja, CM; Gonzalez-Penas, J; Solis, AA; Rebella, M; Gonzalez-Ortega, I; Besga, A; SanJuan, J; Nacher, J; Morro, L; Montserrat, C; Jimenez, E; Da Costa, SG; Baeza, I; de la Serna, E; Rivas, S; Diaz, C; Saiz, PA; Garcia-Alvarez, L; Fraile, MG; Rabadan, AZ; Torio, I; Rodriguez-Jimenez, R; Butjosa, A; Pardo, M; Sarro, S; Pomarol-Clotet, E; Cuadrado, AI; Cuesta, MJ; PEPs Grp.

    Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    ACTA PSYCHIATRICA SCANDINAVICA. 2020; 141(6): 541-552 Nº de citas: 6 [doi:10.1111/acps.13131]